RxDoctor Payments Data

Scott Gutowski, DO

Family Medicine · Jonesville, MINPI 1689690158

Payments from drug & device makers

$13,118in general payments, 2019–2025

Across 825 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$1K
  • AbbVie$1K
  • Pfizer$1K
  • Otsuka America Pharmaceutical, Inc.$934
  • GSK$794
  • plus $6K from 41 others

What the payments were for

  • Food & beverage$13,04699%
  • Education$721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,118 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$99,616
Medicare patients
482
Services billed
2,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin148$133,235
EliquisApixaban138$133,035
OzempicSemaglutide73$90,558
FarxigaDapagliflozin Propanediol89$77,833
Trelegy ElliptaFluticasone/Umeclidin/Vilanter86$76,515
TrulicityDulaglutide56$70,964
XareltoRivaroxaban43$59,091
MounjaroTirzepatide51$55,105
RybelsusSemaglutide14$31,816
EntrestoSacubitril/Valsartan13$15,141
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$13,271
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$9,092
Levothyroxine Sodium572$6,743
PremarinEstrogens, Conjugated15$6,421
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$6,390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$1,002$139,457153 claims
Boehringer IngelheimJardiance$240$133,235148 claims
Lilly USA, LLCTrulicity, Mounjaro$726$126,069107 claims
Novo NordiskOzempic, Rybelsus$1,939$122,37387 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$794$94,364117 claims
AstraZenecaFarxiga, Symbicort$1,042$83,964107 claims
Johnson & JohnsonXarelto$555$59,09143 claims
NovartisEntresto$159$15,14113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Jonesville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →